Metformin administration improves endothelial function in women with polycystic ovary syndrome

European Journal of Endocrinology

Volumn 152, Issue 5, 2005, Pages 749-756

  Diamanti Kandarakis, E ^c   Alexandraki, K ^c   Protogerou, A ^a   Piperi, C ^b   Papamichael, C ^a   Aessopos, A ^c   Lekakis, J ^a   Mavrikakis, M ^a  

^a ALEXANDRA HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; INSULIN; METFORMIN;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; BRACHIAL ARTERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG DOSE REGIMEN; FEMALE; FLOW MEASUREMENT; HEMODYNAMICS; HORMONE METABOLISM; HUMAN; HYPERANDROGENISM; INSULIN RESISTANCE; MATHEMATICAL COMPUTING; METABOLIC PARAMETERS; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; VASODILATATION;

ADULT; BRACHIAL ARTERY; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; FEMALE; GLUCOSE INTOLERANCE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; METFORMIN; POLYCYSTIC OVARY SYNDROME; TESTOSTERONE; VASODILATION;

EID: 19744365285     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.01910     Document Type: Article

References (51)

1. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR & Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the Southeastern United States: a prospective study. Journal of Clinical Endocrinology and Metabolism 1998 83 3078-3082.
2. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, Zapanti ED & Bartzis MI. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. Journal of Clinical Endocrinology and Metabolism 1999 84 4006-4011.
3. Dunaif A, Graf MA, Mandeli J, Laumas V & Dobrjansky A. Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance and/or hyperinsulinemia. Journal of Clinical Endocrinology and Metabolism 1987 65 499-507.
4. Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK & Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with poly-cystic ovary syndrome. Diabetes Care 1999 22 141-146.
5. Dahlgren E, Janson PO, Johansson S, Lapidus L & Oden A. Polycystic ovary syndrome and risk for myocardial infarction: evaluated from a risk factor model based on a prospective population study of women. Acta Obstetrica et Gynecologica Scandinavica 1992 71 599-604.
6. Birdsall MA, Farquhar CM & White RD. Association between polycyctic ovaries and extent of coronary artery disease in women having cardiac catheterization. Annals of Internal Medicine 1997 126 32-35.
7. Pierpoint T, McKeigue PM, Isaacs AJ, Wild SH & Jacobs HS. Mortality of women with polycystic ovary syndrome at long-term follow-up. Journal of Clinical Epidemiology 1998 51 581-586.
8. Talbott E, Clerici A, Berga SL, Kuller L, Guzick D, Detre K, Daniels T & Engberg RA. Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study. Journal of Clinical Epidemiology 1998 51 415-422.
9. Wild SH, Pierpont T, Mckeigue PM & Jacobs HS. Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retro-spective cohort study. Clinical Endocrinology 2000 52 595-600.
10. Christian RC, Dumesic DA, Behrenbeck T, Oberg AL, Sheedy PF 2nd & Fitzpatrick LA. Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2003 88 2562-2568.
11. Talbott EO, Guzick DS, Sutton-Tyrrell K, McHugh-Pemu KP, Zborowski JV, Remsberg KE & Kuller LH. Evidence for an association between polycystic ovary and premature carotid atherosclerosis in middle-aged women. Arteriosclerosis, Thrombosis and Vascular Biology 2000 20 2414-2421.
12. Kelly CJ, Speirs A, Gould GW, Petrie JR, Lyall H & Connell JM. Altered vascular function in young women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2002 87 742-746.
13. Mather JK, Verma S, Corenblum B & Anderson T. Normal endothelial function despite insulin resistance in healthy women with the polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2000 85 1851-1856.
14. Paradisi G, Steinberg HO, Hempfling A, Cronin J, Hook G, Shepard MK & Baron AD. Polycystic ovary syndrome is associated with endothelial dysfunction. Circulation 2001 103 1410-1415.
15. Diamanti-Kandarakis E, Spina G, Kouli C & Migdalis I. Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy. Journal of Clinical Endocrinology and Metabolism 2001 86 4666-4673.
16. Orio F, Palomba S, Cascella T, De Simone B, Di Biase S, Russo T, Labella D, Zullo F, Lombardi G & Colao A. Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2004 89 4588-4593.
17. Petrie JR, Ueda S, Webb DJ, Elliott HL & Connell JM. Endothelial nitric oxide production and insulin sensitivity. A physiological link with implications for pathogenesis of cardiovascular disease. Circulation 1996 93 1331-1333.
18. Seligman B, Biolo A, Polanczyk C, Gross J & Clausell N. Increased plasma levels of endothelin 1 and von Willebrand factor in patients with type 2 diabetes and dyslipidemia. Diabetes Care 2000 23 1395-1400.
19. Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH, Alexander RW & Ganz P. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. New England Journal of Medicine 1986 315 1046-1051.
20. Diamanti-Kandarakis E, Alexandraki K, Protogerou A, Chatzismalis P, Koutsoumpa TH & Lekakis J. Endothelial dysfunction in polycystic ovary syndrome. In Program and Abstracts of The Endocrine Society's 85th Annual Meeting, ENDO 2003. Focus: Cardiovascular Endocrinology. Philadelphia, 19-22 June 2003 (abstract no. P-190).
21. Paradisi G, Steinberg H, Shepard M, Hook G & Baron A. Troglitazone therapy improves endothelial function to near normal levels in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2003 88 576-580.
22. Wheatcroft SB, Williams IL, Shah AM & Kearney MT. Pathophysiological implications of insulin resistance on vascular endothelial function. Diabetic Medicine 2003 20 255-268.
23. Karatzis E, Lekakis J, Papamichael C, Andreadou I, Cimponeriu A, Aznaouridis K, Papaioannou T, Protogerou A & Mavrikakis M. Rapid effect of pravastatin on endothelial function and lipid peroxidation in unstable angina. International Journal of Cardiology 2005 (in press).
24. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK & Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of artherosclerosis. Lancet 1992 340 1111-1115.
25. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J & Vogel R. International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery. Journal of the American College of Cardiology 2002 39 257-265.
26. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G & Quon MJ. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. Journal of Clinical Endocrinology and Metabolism 2000 85 2402-2410.
27. Matsuda M & DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing. comparison with the euglycemic insulin clamp. Diabetes Care 1999 22 1462-1470.
28. Wilson PW Kannel WB, Silbershatz H & D'Agostino RB. Clustering of metabolic factors and coronary heart disease. Archives of Internal Medicine 1999 159 1104-1109.
29. Vogel RA. Coronary risk factors, endothelian function and atherosclerosis: a review. Clinical Cardiology 1997 20 426-432.
30. Porta M, La Selva M, Molinatti P & Molinatti GM. Endothelial cell function in diabetic microangiopathy. Diabetologia 1987 30 601-609.
31. Takahashi K, Ghatei MA, Lam H-C, O'Halloran DJ & Bloom SR. Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia 1990 33 306-310.
32. Hopfner RL & Gopalakrishnan V. Endothelin: emerging role in diabetic vascular complications. Diabetologia 1999 42 1383-1394.
33. Caballero AE, Arora S, Saouaf R, Lim SC, Smakowski P, Park J, King GL, LoGerfo FW, Horton ES & Veves A. Microvascular and macrovascular reactivity is reduced in subjects at a risk for type 2 diabetes. Diabetes 1999 48 1856-1862.
34. Ferri C, Bellini C, Desideri G, Di Francesco L, Baldoncini R, Santucci A & De Mattia G. Plasma endothelin-1 levels in obese hypertensive and normotensive men. Diabetes 1995 44 431-436.
35. Ferri C, Bellini C, Desideri G, Baldoncini R, Properzi G, Santucci A & De Mattia G. Circulating endothelin-1 levels in obese patients with the metabolic syndrome. Experimental and Clinical Endocrinology and Diabetes 1997 105 (Suppl 2) 38-40.
36. Laurent S, Lacolley P, Brunel P, Laloux B, Pannier B & Safar M. Flow-dependent vasodilation of brachial artery in essential hypertension. American Journal of Physiology 1990 258 H1004-H1011.
37. McVeigh GE, Brennan GM, Johnston GD, McDermott BJ, McGrath LT, Henry WR, Andrews JW & Hayes JR. Impaired endothelium dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1992 35 771-776.
38. Wheatcroft SB, Williams IL, Shah AM & Kearney MT. Pathophysiological implications of insulin resistance on vascular endothelial function. Diabetic Medicine 2003 20 255-268.
39. Montagnani M & Quon MJ. Insulin action in vascular endothelium: potential mechanisms linking insulin resistance with hypertension. Diabetes, Obesity and Metabolism 2000 2 285-292.
40. Dunaif A, Wu XQ, Lee A & Diamanti-Kandarakis E. Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS). American Journal of Physiology. Endocrinology and Metabolism 2001 281 E392-E399.
41. Jiang ZY, Zhou QL, Chatterjee A, Feener EP, Myers MG Jr, White MF & King GL. Endothelin-1 modulates insulin signaling through phosphatidyl 3-kinase pathway in vascular smooth muscle cells. Diabetes 1999 48 1120-1130.
42. Harrison DG. Cellular and molecular mechanisms of endothelial cell dysfunction. Journal of Clinical Investigation 1997 100 2153-2157.
43. Cusi K, Maezono K, Osman A, Pendergrass M, Patti ME, Pratipanawatr T, DeFronzo RA, Kahn CR & Mandarino LJ. Insulin resistance differentially affects the PI3-kinase- and MAP kinase-mediated signaling in human muscle. Journal of Clinical Investigation 2000 105 311-320.
44. Lin AL, Gonzalez R Jr, Carey KD & Shain SA. Estradiol-17 beta affects estrogen receptor distribution and elevates progesterone receptor content in baboon aorta. Arteriosclerosis 1986 6 495-504.
45. Diamanti-Kandarakis E, Kouli C, Alexandraki K & Spina G. Failure of mathematical indices to accurately assess insulin resistance in lean, overweight, or obese women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2004 89 1273-1276.
46. Diamanti-Kandarakis E, Kouli CR, Tsianateli TC & Bergiele AT. Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome. European Journal of Endocrinology 1998 138 269-274.
47. Landin K, Tengborn L & Smith U. Treating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factors. Journal of Internal Medicine 1991 229 181-187.
48. Ingegno MD, Money SK, Thelmo W, Greene GL, Davidian M, Jaffe BM & Pertschuk LP. Progesterone receptors in the human heart and great vessels. Laboratory Investigation 1988 59 353-356.
49. Marin P, Holmang S, Jonsson L, Sjostrom L, Kvist H, Holm G, Lindstedt G & Bjorntorp P. The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. International Journal of Obesity and Related Metabolic Disorders 1992 16 991-997.
50. Diamanti-Kandarakis E, Paterakis T, Rizos D, Chatzismalis P, Alexandraki K, Nikolopoulou M, Koutsouba T & Kreatsas G. Adhesion Molecules in PCOS. In Program and Abstracts of The Endocrine Society's 84th Annual Meeting, ENDO 2002. Focus: The Impact of The Human Genome on Endocrinology. San Francisco, 19-22 June 2002 (abstract no. P2-615).
51. Diamanti-Kandarakis E, Mitrakou A, Raptis S, Tolis G & Duleba AJ. The effect of a pure antiandrogen receptor blocker, flutamide, on the lipid profile in the polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 1998 83 2699-2705.